These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 16456578)

  • 1. Chemotherapy resistance of glioblastoma stem cells.
    Eramo A; Ricci-Vitiani L; Zeuner A; Pallini R; Lotti F; Sette G; Pilozzi E; Larocca LM; Peschle C; De Maria R
    Cell Death Differ; 2006 Jul; 13(7):1238-41. PubMed ID: 16456578
    [No Abstract]   [Full Text] [Related]  

  • 2. Brain tumor stem cells as research and treatment targets.
    Hide T; Takezaki T; Nakamura H; Kuratsu J; Kondo T
    Brain Tumor Pathol; 2008; 25(2):67-72. PubMed ID: 18987831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verotoxin induces apoptosis and the complete, rapid, long-term elimination of human astrocytoma xenografts in nude mice.
    Arab S; Rutka J; Lingwood C
    Oncol Res; 1999; 11(1):33-9. PubMed ID: 10451029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation therapy exerts antitumor effects on stem-like glioma cells.
    Campos B; Wan F; Farhadi M; Ernst A; Zeppernick F; Tagscherer KE; Ahmadi R; Lohr J; Dictus C; Gdynia G; Combs SE; Goidts V; Helmke BM; Eckstein V; Roth W; Beckhove P; Lichter P; Unterberg A; Radlwimmer B; Herold-Mende C
    Clin Cancer Res; 2010 May; 16(10):2715-28. PubMed ID: 20442299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells.
    Warrier S; Balu SK; Kumar AP; Millward M; Dharmarajan A
    Oncol Res; 2013; 21(2):93-102. PubMed ID: 24406045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic blockade of chloride channel synergistically enhances apoptosis of chemotherapeutic drug-resistant cancer stem cells.
    Kang MK; Kang SK
    Biochem Biophys Res Commun; 2008 Sep; 373(4):539-44. PubMed ID: 18590702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-29a-Mediated CD133 Expression Contributes to Cisplatin Resistance in CD133
    Yang L; Li N; Yan Z; Li C; Zhao Z
    J Mol Neurosci; 2018 Nov; 66(3):369-377. PubMed ID: 30267383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel function of the thyroid hormone analog tetraiodothyroacetic acid: a cancer chemosensitizing and anti-cancer agent.
    Rebbaa A; Chu F; Davis FB; Davis PJ; Mousa SA
    Angiogenesis; 2008; 11(3):269-76. PubMed ID: 18386142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic inhibition of tumor growth by combination treatment with drugs against different subpopulations of glioblastoma cells.
    Chang CH; Liu WT; Hung HC; Gean CY; Tsai HM; Su CL; Gean PW
    BMC Cancer; 2017 Dec; 17(1):905. PubMed ID: 29284440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-elemene inhibits proliferation of human glioblastoma cells through the activation of glia maturation factor β and induces sensitization to cisplatin.
    Zhu T; Xu Y; Dong B; Zhang J; Wei Z; Xu Y; Yao Y
    Oncol Rep; 2011 Aug; 26(2):405-13. PubMed ID: 21519795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid receptor activation triggering downregulation of cAMP improves effectiveness of anti-cancer drugs in treatment of glioblastoma.
    Friesen C; Hormann I; Roscher M; Fichtner I; Alt A; Hilger R; Debatin KM; Miltner E
    Cell Cycle; 2014; 13(10):1560-70. PubMed ID: 24626197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward the development of innovative bifunctional agents to induce differentiation and to promote apoptosis in leukemia: clinical candidates and perspectives.
    Vizirianakis IS; Chatzopoulou M; Bonovolias ID; Nicolaou I; Demopoulos VJ; Tsiftsoglou AS
    J Med Chem; 2010 Oct; 53(19):6779-810. PubMed ID: 20925433
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of stealthy liposomal topotecan plus amlodipine on the multidrug-resistant leukaemia cells in vitro and xenograft in mice.
    Li X; Lu WL; Liang GW; Ruan GR; Hong HY; Long C; Zhang YT; Liu Y; Wang JC; Zhang X; Zhang Q
    Eur J Clin Invest; 2006 Jun; 36(6):409-18. PubMed ID: 16684125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orthotopic glioblastoma stem-like cell xenograft model in mice to evaluate intra-arterial delivery of bevacizumab: from bedside to bench.
    Burkhardt JK; Hofstetter CP; Santillan A; Shin BJ; Foley CP; Ballon DJ; Pierre Gobin Y; Boockvar JA
    J Clin Neurosci; 2012 Nov; 19(11):1568-72. PubMed ID: 22985932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins.
    Tagscherer KE; Fassl A; Campos B; Farhadi M; Kraemer A; Böck BC; Macher-Goeppinger S; Radlwimmer B; Wiestler OD; Herold-Mende C; Roth W
    Oncogene; 2008 Nov; 27(52):6646-56. PubMed ID: 18663354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors.
    Dhandapani KM; Mahesh VB; Brann DW
    J Neurochem; 2007 Jul; 102(2):522-38. PubMed ID: 17596214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatidylinositol 3-kinase inhibition broadly sensitizes glioblastoma cells to death receptor- and drug-induced apoptosis.
    Opel D; Westhoff MA; Bender A; Braun V; Debatin KM; Fulda S
    Cancer Res; 2008 Aug; 68(15):6271-80. PubMed ID: 18676851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
    Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal differentiation of glioblastoma stem cells.
    Ricci-Vitiani L; Pallini R; Larocca LM; Lombardi DG; Signore M; Pierconti F; Petrucci G; Montano N; Maira G; De Maria R
    Cell Death Differ; 2008 Sep; 15(9):1491-8. PubMed ID: 18497759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between tumor stem cell heterogeneity and responsiveness to chemotherapy.
    Skipper HE; Simpson-Herren L
    Important Adv Oncol; 1985; ():63-77. PubMed ID: 3870935
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.